Back
Structure Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
12
GPCR
Structure Therapeutics
Last Price:
$29.73
Seasonality Move:
-41.18%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight selling pressure.
Structure Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.54 | Sell |
| 20-day SMA: | 31.88 | Sell |
| 50-day SMA: | 35.05 | Sell |
| 200-day SMA: | 38.64 | Sell |
| 8-day EMA: | 29.55 | Sell |
| 20-day EMA: | 31.44 | Sell |
| 50-day EMA: | 34.15 | Sell |
| 200-day EMA: | 37.79 | Sell |
Structure Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.85 | Sell |
| Relative Strength Index (14 RSI): | 37.23 | Sell |
| Chaikin Money Flow: | -69290 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.9 - 34.16) | Sell |
| Bollinger Bands (100): | (33.21 - 40.79) | Sell |
Structure Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 28.25 while GPCR 8-day simple moving average is 29.54, which is a Sell signal.
-
The stock price of GPCR is 28.25 while Structure Therapeutics 20-day SMA is 31.88, which makes it a Sell.
-
Structure Therapeutics 50-day simple moving average is 35.05 while GPCR share price is 28.25, making it a Sell technically.
-
GPCR stock price is 28.25 and Structure Therapeutics 200-day simple moving average is 38.64, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
12
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a SellThe current Structure Therapeutics [GPCR] share price is $28.25. The Score for GPCR is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics Stock Info
Market Cap:
1.6B
Price in USD:
28.25
Share Volume:
247.5K
Structure Therapeutics 52-Week Range
52-Week High:
62.74
52-Week Low:
26.23
Sell
12
Structure Therapeutics (GPCR)
is a Sell
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?The Structure Therapeutics stock price is 28.25 USD today.
-
Will GPCR stock go up or go down?Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Structure Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is overvalued.
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 28.25 while GPCR 8-day exponential moving average is 29.55, which is a Sell signal.
-
The stock price of GPCR is 28.25 while Structure Therapeutics 20-day EMA is 31.44, which makes it a Sell.
-
Structure Therapeutics 50-day exponential moving average is 34.15 while GPCR share price is 28.25, making it a Sell technically.
-
GPCR stock price is 28.25 and Structure Therapeutics 200-day simple moving average is 37.79, creating a Sell signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.08 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
-
GPCR Moving Average Covergence Divergence (MACD) indicator is -1.85, suggesting Structure Therapeutics is a Sell
-
Structure Therapeutics Relative Strength Index (RSI) is 37.23, which suggest Structure Therapeutics is oversold
-
The Bollinger Bands (25) for Structure Therapeutics is (29.9 - 34.16), which suggest Structure Therapeutics is a Sell
-
The Bollinger Bands (100) for Structure Therapeutics is (33.21 - 40.79), which suggest Structure Therapeutics is a Sell
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.